Ultragenyx and Mereo advance UX143 osteogenesis imperfecta study to final analysis
Go back to Ultragenyx and Mereo advance UX143 osteogenesis imperfecta study to final analysis| Mirenco, Inc. (NASDAQ: MREO) | Delayed: 0.33 +0.01 (3.13%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.32 | 52 Week High | $0.01 | |||
| Open | $0.32 | 52 Week Low | $0.00 | |||
| Day High | $0.34 | P/E | N/A | |||
| Day Low | $0.32 | EPS | $-0.02 | |||
| Volume | 1,428,863 | |||||
| ULTRAGENYX PHARM (NASDAQ: RARE) | Delayed: 33.47 +1.09 (3.37%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $32.38 | 52 Week High | $117.12 | |||
| Open | $32.80 | 52 Week Low | $46.52 | |||
| Day High | $33.50 | P/E | N/A | |||
| Day Low | $32.48 | EPS | $-1.97 | |||
| Volume | 1,239,269 | |||||
